Galmed Pharmaceuticals' Unattributed Round

Galmed Pharmaceuticals raised a round of funding on December 21, 2011. Investors include CHealth Fund.

Galmed Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development and commercialization of a novel, once-daily, oral therapy for the treatment of liver diseases and chole…

Articles about Galmed Pharmaceuticals' Unattributed Round: